SSN 2410-7751 (Print)
ISSN 2410-776X (Online)
Biotechnologia Acta Т. 18, No. 2, 2025
P. 89-91 , Bibliography 4 , Engl.
UDC 616.155.392-089.843:611.018.46+616-097
doi: https://doi.org/10.15407/biotech18.02.089
LIMITATIONS OF HUMAN LEUKOCYTE ANTIGEN MOLECULAR TYPING METHODS FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA RELAPSE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
L.O. Sishchuk, I.I. Tubaltseva, N.A. Tsokolenko, A.O. Maksymchuk, A. V. Kukhol, V.V. Andrusenko, A.O. Mazanova, Y.A. Hrohul
National Specialized Children's Hospital "OKHMATDYT" of the Ministry of Health of Ukraine, Kyiv
Aim. The work purposed to compare molecular typing methods with different resolutions in clinical cases without loss of heterozygosity (LOH) in HLA genes.
Methods. HLA typing was performed using molecular techniques based on sequence-specific primers (SSP) or high-resolution sequencing (NGS and Sanger sequencing).
Results. the presence of an extra allelic variant in testing DNA samples was determined only with the low-resolution SSP method. At the same time, any type of sequencing did not allow for distinguishing donors’ alleles from patients.
Conclusion. Despite the high sensitivity of NGS and Sanger sequencing, the use of these methods is associated with difficulties in accurately determining the absence of HLA-LOH.
Keywords: HLA-LOH, HLA typing, hematopoietic stem cell transplantation, sequencing.
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2025
References
1. Arnold, P. Y. (2022). HLA Loss and Detection in the Setting of Relapse from HLA-Mismatched
Hematopoietic Cell Transplant. Hum. Immunol., 83, 712–720. https://doi.org/10.1016/j.
humimm.2022.08.004.
2. Geo, J. A., Ameen, R., Shemmari, S. A., Thomas, J. (2024). Advancements in HLA Typing
Techniques and Their Impact on Transplantation Medicine. Med. Princ. Pract., 33, 215–231.
https://doi.org/10.1159/000538176.
3. Lee, M. Y., You, E. (2024). The Importance of Confirming False Homozygosity in Pretransplant
HLA Typing Results of Patients with Hematologic Malignancies. Int. J. Med. Sci., 21, 2430–2436.
https://doi.org/10.7150/ijms.99883.
4. Lozac’hmeur, A., Danek, T., Yang, Q., Rosasco, M. G., Welch, J. S., Go, W. Y., Eric, W.,
Ng, E. W., …, Hecht, J. R. (2024). Detecting HLA Loss of Heterozygosity within a Standard
Diagnostic Sequencing Workflow for Prognostic and Therapeutic Opportunities. NPJ Precision
Oncol., 8, 174. https://doi.org/10.1038/s41571-024-00814-6..